Article ID Journal Published Year Pages File Type
3390804 Rheumatic Disease Clinics of North America 2008 12 Pages PDF
Abstract

The focus of pharmacologic treatment of osteoarthritis (OA) includes targets from the cell and cytokine level to the larger joint components such as cartilage, bone, innervations, and vascular supply. The most important goals of therapy in patients who have OA are pain management, improvement in function and disability, and ultimately disease modification. This article discusses the current pharmacologic regimens available to address these goals. Specific attention is paid to current trends and controversies related to pharmacologic management, including the use of oral, topical, and injectable agents.

Related Topics
Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology
Authors
, ,